Skip to main content

Table 1 The level of ACE2 in plasma of breast cancer patients

From: Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy

Group

Breast cancer patients

ACE2 (ng/mL)

P-value

Chemo-resistant

57

17.46

< 0.0001

Chemo-sensitive

54

13.47